Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?
- PMID: 16023222
- DOI: 10.1016/j.jneuroim.2005.04.023
Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?
Abstract
Since the discovery of the cannabinoid receptors and their endogenous ligands, significant advances have been made in studying the physiological function of the endocannabinoid system. The presence of cannabinoid receptors on cells of the immune system and anecdotal and historical evidence suggesting that cannabis use has potent immuno-modulatory effects, has led to research directed at understanding the function and role of these receptors within the context of immunological cellular function. Studies from chronic cannabis smokers have provided much of the evidence for immunomodulatory effects of cannabis in humans, and animal and in vitro studies of immune cells such as T cells and macrophages have also provided important evidence. Cannabinoids can modulate both the function and secretion of cytokines from immune cells. Therefore, cannabinoids may be considered for treatment of inflammatory disease. This review article will highlight recent research on cannabinoids and how they interact with the immune system and also their potential use as therapeutic agents for a number of inflammatory disorders.
Similar articles
-
Cannabinoids and the immune system: an overview.Immunobiology. 2010 Aug;215(8):588-97. doi: 10.1016/j.imbio.2009.12.005. Epub 2010 Jan 4. Immunobiology. 2010. PMID: 20153077 Review.
-
Endocannabinoids in the immune system and cancer.Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):319-32. doi: 10.1054/plef.2001.0355. Prostaglandins Leukot Essent Fatty Acids. 2002. PMID: 12052046 Review.
-
Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.Ann Pharmacother. 2006 Feb;40(2):251-60. doi: 10.1345/aph.1G217. Epub 2006 Jan 31. Ann Pharmacother. 2006. PMID: 16449552 Review.
-
The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.Am J Ther. 2007 Sep-Oct;14(5):475-83. doi: 10.1097/MJT.0b013e3180a5e581. Am J Ther. 2007. PMID: 17890938 Review.
-
Cannabinoids and gastrointestinal motility: animal and human studies.Eur Rev Med Pharmacol Sci. 2008 Aug;12 Suppl 1:81-93. Eur Rev Med Pharmacol Sci. 2008. PMID: 18924447 Review.
Cited by
-
Case report: Cannabinoid therapy for discoid lupus erythematosus in a dog.Front Vet Sci. 2024 Feb 9;11:1309167. doi: 10.3389/fvets.2024.1309167. eCollection 2024. Front Vet Sci. 2024. PMID: 38406630 Free PMC article.
-
Cannabinoids in Periodontology: Where Are We Now?Antibiotics (Basel). 2023 Nov 30;12(12):1687. doi: 10.3390/antibiotics12121687. Antibiotics (Basel). 2023. PMID: 38136721 Free PMC article. Review.
-
Protective Application of Chinese Herbal Compounds and Formulae in Intestinal Inflammation in Humans and Animals.Molecules. 2023 Sep 26;28(19):6811. doi: 10.3390/molecules28196811. Molecules. 2023. PMID: 37836654 Free PMC article. Review.
-
Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases.Int J Mol Sci. 2023 Sep 28;24(19):14677. doi: 10.3390/ijms241914677. Int J Mol Sci. 2023. PMID: 37834122 Free PMC article. Review.
-
Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms.Cells. 2023 Mar 9;12(6):848. doi: 10.3390/cells12060848. Cells. 2023. PMID: 36980189 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
